Literature DB >> 35226303

Plasma neurofilament light levels correlate with white matter damage prior to Alzheimer's disease: results from ADNI.

Fardin Nabizadeh1,2, Mohammad Balabandian3,4, Mohammad Reza Rostami3,4, Samuel Berchi Kankam5, Fatemeh Ranjbaran6, Mahsa Pourhamzeh7.   

Abstract

BACKGROUND: The blood biomarker neurofilament light (NFL) is one of the most widely used for monitoring Alzheimer's disease (AD). According to recent research, a higher NFL plasma level has a substantial predictive value for cognitive deterioration in AD patients. Diffusion tensor imaging (DTI) is an MRI-based approach for detecting neurodegeneration, white matter (WM) disruption, and synaptic damage. There have been few studies on the relationship between plasma NFL and WM microstructure integrity. AIMS: The goal of the current study is to assess the associations between plasma levels of NFL, CSF total tau, phosphorylated tau181 (P-tau181), and amyloid-β (Aβ) with WM microstructural alterations.
METHODS: We herein have investigated the cross-sectional association between plasma levels of NFL and WM microstructural alterations as evaluated by DTI in 92 patients with mild cognitive impairment (MCI) provided by Alzheimer's Disease Neuroimaging Initiative (ADNI) participants. We analyzed the potential association between plasma NFL levels and radial diffusivity (RD), axial diffusivity (AxD), mean diffusivity (MD), and fractional anisotropy (FA) in each region of the Montreal Neurological Institute and Hospital (MNI) atlas, using simple linear regression models stratified by age, sex, and APOE ε4 genotype.
RESULTS: Our findings demonstrated a significant association between plasma NFL levels and disrupted WM microstructure across the brain. In distinct areas, plasma NFL has a negative association with FA in the fornix, fronto-occipital fasciculus, corpus callosum, uncinate fasciculus, internal capsule, and corona radiata and a positive association with RD, AxD, and MD values in sagittal stratum, corpus callosum, fronto-occipital fasciculus, corona radiata, internal capsule, thalamic radiation, hippocampal cingulum, fornix, and cingulum. Lower FA and higher RD, AxD, and MD values are related to demyelination and degeneration in WM.
CONCLUSION: Our findings revealed that the level of NFL in the blood is linked to WM alterations in MCI patients. Plasma NFL has the potential to be a biomarker for microstructural alterations. However, further longitudinal studies are necessary to validate the predictive role of plasma NFL in cognitive decline.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Alzheimer’s disease; Biomarker; Diffusion tensor imaging; Mild cognitive impairment; Neurofilament light chain; White matter

Year:  2022        PMID: 35226303     DOI: 10.1007/s40520-022-02095-y

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  40 in total

1.  Neurofilament light chain protein in neurodegenerative dementia: A systematic review and network meta-analysis.

Authors:  Yinan Zhao; Yanguo Xin; Su Meng; Zhiyi He; Wenyu Hu
Journal:  Neurosci Biobehav Rev       Date:  2019-04-24       Impact factor: 8.989

2.  Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.

Authors:  Niklas Mattsson; Nicholas C Cullen; Ulf Andreasson; Henrik Zetterberg; Kaj Blennow
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

3.  Plasma phosphorylated-tau181 levels reflect white matter microstructural changes across Alzheimer's disease progression.

Authors:  Fardin Nabizadeh; Mahsa Pourhamzeh; Saghar Khani; Ayda Rezaei; Fatemeh Ranjbaran; Niloofar Deravi
Journal:  Metab Brain Dis       Date:  2022-01-11       Impact factor: 3.584

Review 4.  Alzheimer's disease.

Authors:  Carly Oboudiyat; Hilary Glazer; Alon Seifan; Christine Greer; Richard S Isaacson
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

5.  Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.

Authors:  Johanna Gaiottino; Niklas Norgren; Ruth Dobson; Joanne Topping; Ahuva Nissim; Andrea Malaspina; Jonathan P Bestwick; Andreas U Monsch; Axel Regeniter; Raija L Lindberg; Ludwig Kappos; David Leppert; Axel Petzold; Gavin Giovannoni; Jens Kuhle
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

Review 6.  Biomarkers for Alzheimer's Disease Diagnosis.

Authors:  Vasileios Mantzavinos; Athanasios Alexiou
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

7.  Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease.

Authors:  Yung-Shuan Lin; Wei-Ju Lee; Shuu-Jiun Wang; Jong-Ling Fuh
Journal:  Sci Rep       Date:  2018-11-26       Impact factor: 4.379

8.  Time-Dependent Changes in the Serum Levels of Neurobiochemical Factors After Acute Methadone Overdose in Adolescent Male Rat.

Authors:  Leila Ahmad-Molaei; Mahsa Pourhamzeh; Reza Ahadi; Fariba Khodagholi; Hossein Hassanian-Moghaddam; Abbas Haghparast
Journal:  Cell Mol Neurobiol       Date:  2020-07-25       Impact factor: 5.046

9.  Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease.

Authors:  Ignacio Illán-Gala; Alberto Lleo; Anna Karydas; Adam M Staffaroni; Henrik Zetterberg; Rajeev Sivasankaran; Lea T Grinberg; Salvatore Spina; Joel H Kramer; Eliana M Ramos; Giovanni Coppola; Renaud La Joie; Gil D Rabinovici; David C Perry; Maria Luisa Gorno-Tempini; William W Seeley; Bruce L Miller; Howard J Rosen; Kaj Blennow; Adam L Boxer; Julio C Rojas
Journal:  Neurology       Date:  2020-11-16       Impact factor: 11.800

10.  Relationship Between DTI Metrics and Cognitive Function in Alzheimer's Disease.

Authors:  Chantel D Mayo; Mauricio A Garcia-Barrera; Erin L Mazerolle; Lesley J Ritchie; John D Fisk; Jodie R Gawryluk
Journal:  Front Aging Neurosci       Date:  2019-01-09       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.